Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tysk

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Alimentary Pharmacology & Therapeutics|October 13, 2010
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab studyA Gustavsson, G Järnerot, E Hertervig, et al.
The American Journal of Gastroenterology|January 29, 2009
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohortR Thiébaut, S Kotti, C Jung, et al.
Gut|November 15, 2000
Genetic analyses of chromosome 12 loci in Crohn's diseaseS Lesage, H Zouali, J F Colombel, et al.
Inflammatory Bowel Diseases|July 21, 2010
RIP2 polymorphisms in inflammatory bowel diseasesR Thiébaut, V Douchin, C Jung, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2013
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patientsM Sjöberg, A Magnuson, J Björk, et al.
European Journal of Human Genetics : EJHG|January 10, 2002
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel diseaseH Zouali, M Chamaillard, S Lesage, et al.
Gut|December 13, 2002
CARD4/NOD1 is not involved in inflammatory bowel diseaseH Zouali, S Lesage, F Merlin, et al.
Nature|June 1, 2001
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseJ P Hugot, M Chamaillard, H Zouali, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Alimentary Pharmacology & Therapeutics|October 13, 2010
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab studyA Gustavsson, G Järnerot, E Hertervig, et al.
The American Journal of Gastroenterology|January 29, 2009
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohortR Thiébaut, S Kotti, C Jung, et al.
Gut|November 15, 2000
Genetic analyses of chromosome 12 loci in Crohn's diseaseS Lesage, H Zouali, J F Colombel, et al.
Inflammatory Bowel Diseases|July 21, 2010
RIP2 polymorphisms in inflammatory bowel diseasesR Thiébaut, V Douchin, C Jung, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2013
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patientsM Sjöberg, A Magnuson, J Björk, et al.
European Journal of Human Genetics : EJHG|January 10, 2002
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel diseaseH Zouali, M Chamaillard, S Lesage, et al.
Gut|December 13, 2002
CARD4/NOD1 is not involved in inflammatory bowel diseaseH Zouali, S Lesage, F Merlin, et al.
Nature|June 1, 2001
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseJ P Hugot, M Chamaillard, H Zouali, et al.
Pageof 7